PMGC (ELAB) Stock: Buy, Sell, or Hold?
ELAB - PMGC Holdings Inc. Common Stock
$4.52
-0.08 (-1.74%)
▼
5d:
-13.58%
30d:
+402.22%
90d:
+189.74%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When ELAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ELAB is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ELAB is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ELAB is currently trading at $4.52, which is considered slightly high relative to its 30-day fair value range of $0.98 to $5.57.
Technical Outlook: Technically, ELAB is in a downtrend. The price is currently testing key support at $4.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELAB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELAB is in a downtrend. The price is currently testing key support at $4.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELAB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.98 -
$5.57
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
35.3%
All Signals
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.98 -
$5.57
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.40
Resistance Level
$5.97
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Revenue Growth (YoY)
-45.8%
Share & Embed Analysis
Last updated: September 12, 2026 8:00 PM ET
Data refreshes hourly during market hours. Next update: 9:00 PM
Data refreshes hourly during market hours. Next update: 9:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 41 HOLD |
